explore -WSS

explore

author：leisure time 2025-09-30 22:28:32 - browse：164

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Texas Medical Board asked to define abortion emergency exception

WSS

The CDC's new social media misinformation war

Surgery pushed Ben Carson to fame

AstraZeneca stays mum on Medicare drug pricing negotiations

Updated Covid vaccine has 54% effectiveness, new study suggests

SCOTUS questions limit to govt efforts to fight misinformation

Argenx readies a blockbuster opportunity with drug for autoimmune disease

leisure time

explore

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The CDC's new social media misinformation war

New air purifier tech could be key to improving indoor air quality

The CDC's new social media misinformation war

Continuity nursing helped my family in our darkest PICU moments

Virtual Event: March of the Biosimilars

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Future doctors should be trained to promote social change

New air purifier tech could be key to improving indoor air quality

AstraZeneca to buy developer of next

hotspot

AstraZeneca to buy developer of next

Readout LOUD: Venture capital, Gilead, and more M&A

Cano Health’s bankruptcy is a warning for Medicare Advantage

Neuroscience’s long legacy of racism

Plastic surgeons increase patient psychiatric screenings

A protest over insulin prices is seen as a fight for life

Wikipedia

Wikipedia

leisure time

entertainment